Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer Meeting Abstract
| Authors: | Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; Majid, M.; Norton, L.; Rosen, N.; Chandarlapaty, S. |
| Abstract Title: | Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer |
| Meeting Title: | 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 71 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2011 Dec 6-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2011-12-01 |
| Language: | English |
| ACCESSION: | WOS:000209699800096 |
| DOI: | 10.1158/0008-5472.SABCS11-PD09-08 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PD09-08 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work